View drug registration information details.


ItemsRegistration information
ID255
No255
Brand NamePOMMADX
IngredientsPOMALIDOMIDE 4 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 21 TABLET'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsUSED IN COMBINATION WITH DEAMETHASONE TO TREAT MULTIPLE MYELOMA (A TYPE OF CANCER OF THE BONE MARROW) THAT HAS NOT IMPROVED DURING OR WITHIN 60 DAYS OF TREATMENT WITH AT LEAST TWO OTHER MEDICATIONS INCLUDING LENALIDOMIDE AND PROTEASOME INHIBITOR.
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionBLUE CAPSULE
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No10 L 1024/23
FDD Registration Date10-OCT-2023
Expiry Date09-OCT-2026

Back to drug list